Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03270111 · ClinicalTrials.gov registry record · NA
High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women
A NA study, sponsored by Carol Fabian, MD.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03270111: Completed NA study, sponsored by Carol Fabian, MD.
NCT03270111 is a NA study that has completed, run by Carol Fabian, MD. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03270111, a NA study, has completed, sponsored by Carol Fabian, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this second pilot study is to extend the feasibility demonstrated in NCT02963740 that the intervention achieves high levels of moderate to vigorous physical activity (MVI PA) and modulates risk biomarkers for breast cancer and cardiovascular disease in older, obese sedentary breast cancer survivors who are undergoing moderate calorie restriction.
Primary Outcome
Adherence is defined as the percent of monitored sessions at the YMCA attended by the participant.
Interventions
- BEHAVIORAL Group Phone Calls
- BEHAVIORAL Supervised Exercise
- BEHAVIORAL Home-based Exercise
- BEHAVIORAL Reduced Energy Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2018-07-24 |
| Phase | NA |
What the finished NCT03270111 record still lists
NCT03270111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Group Phone Calls is the first listed.
NCT03270111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03270111 about?
NCT03270111 is a clinical study titled "High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women". The purpose of this second pilot study is to extend the feasibility demonstrated in NCT02963740 that the intervention achieves high levels of moderate to vigorous physical activity (MVI PA) and modulates risk biomarkers for breast cancer and cardiovascular disease in older, obese sedentary breast ca...
What is the current status of trial NCT03270111?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2017-09-25. Estimated completion is 2018-07-24.
What interventions are being tested in trial NCT03270111?
The interventions under investigation include: Group Phone Calls (BEHAVIORAL), Supervised Exercise (BEHAVIORAL), Home-based Exercise (BEHAVIORAL), Reduced Energy Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03270111?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03270111's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI